LSD Microdosing for Mood & Mental Health
A Conversation with New Zealand’s Pioneering Psychedelic Researchers
Join pioneering researchers Dr. Suresh Muthukumaraswamy and Dr. Rachael Sumner for a live webinar on LSD microdosing. Learn how their government-sanctioned clinical trials are exploring its potential to treat mood disorders and improve mental health.
Wednesday, October 22nd, 2025 (online)
12:00 PM PST | 3:00 PM EST | 8:00 PM GMT
60 minutes with live Q&A
Presented by:
Secure your spot
Few substances in modern history have carried as much intrigue, controversy, and potential as LSD. First synthesized in 1938 by Swiss chemist Albert Hofmann, LSD quickly became both a subject of scientific fascination and a catalyst for cultural exploration.
In the 1950s and 1960s, it was studied in the United States and beyond for its potential in treating depression, anxiety, and addiction, while simultaneously inspiring music, art, and countercultural movements, until prohibition halted nearly all research for decades.
Today, a new era of LSD research for mental health is emerging. At the forefront of this renaissance are Dr. Suresh Muthukumaraswamy and Dr. Rachael Sumner, researchers at the University of Auckland in New Zealand, leading the world’s first government-sanctioned clinical trials of LSD microdosing for mood disorders.
Their groundbreaking work is moving the conversation from anecdote to evidence, shedding light on how microdosing LSD may affect mood, cognition, sleep, and mental health.
Join Microdosing Collective and Third Wave for a live webinar with Dr. Suresh Muthukumaraswamy and Dr. Rachael Sumner for an inside look at pioneering LSD microdosing research and what it could mean for the future of mental health.
What You’ll Learn:
- Key findings from New Zealand’s first government-sanctioned, at-home LSD microdosing trial
- The neuroscience of microdosing and how sub-hallucinogenic doses influence brain activity, mood, cognition, and well-being
- What clinical studies are revealing about LSD’s antidepressant potential
- The future of LSD microdosing for depression, anxiety, and mood disorders
- Live Q&A with Drs. Muthukumaraswamy and Sumner to address your most pressing questions
This Webinar Is For You If:
You’re curious about how LSD microdosing may support mood and mental health.
You’re a clinician or therapist exploring emerging tools for treatment-resistant depression and anxiety.
You want to understand the science, not just the hype, behind microdosing.
You’re interested in the global movement to bring psychedelics back into medicine, ethically and safely.
Webinar Speakers:
Professor Suresh Muthukumaraswamy
Neuropharmacologist and Lead Researcher at the University of Auckland
Dr. Rachael Sumner
Clinical Researcher at the University of Auckland
Paul F. Austin
Co-Founder and Educational Director of Microdosing Collective, Founder of Third Wave and the Psychedelic Coaching Institute
Stephanie Karzon
Neuropharmacologist, Research Director at Microdosing Collective
Can’t attend live?
Register anyway for free – we’ll send you the recording!